The InterX team is an international group of physicists, mathematicians, chemists, biologists, and software engineers who are passionate about making an enduring contribution to science. We are looking for exceptional individuals who want to be a part of cutting-edge physics and biophysics research.
Gary L. Wilcox, Ph.D.
Former Scientific Advisory Board Member
The late Dr. Gary Wilcox (1947-2021) was Chairman, CEO and a co-founder of Cocrystal Pharma Inc., an antiviral drug discovery company. From 1993-2007, he was Executive Vice President of Operations and a member of the board of directors of Icos Corporation, where he played a key role in the development of Cialis. In 1982 Gary co-founded Ingene Inc., serving as its Chairman, President and CEO through private financing, an IPO and a successful merger with Xoma Corporation in 1989. Ingene patented fundamental gene expression technologies and novel antibodies, including an antibody patent licensed to Genentech for the anti-cancer drug, Rituxin. From 1974 until 1984, Gary was a Professor of Microbiology and a member of the Molecular Biology Institute at UCLA. He was the recipient of the American Cancer Society Faculty Research Award in 1977 for his pioneering work in positive control of gene expression. Gary has served on the Board of Directors of NASDAQ, New York and London Stock Exchange companies, as well as several private technology companies. He is the author of 72 scientific papers and a named inventor on 15 patents. Gary received a Ph.D. and M.A. in molecular biology and biochemistry from UC Santa Barbara in 1972, and a B.A. in biology from UC Santa Barbara in 1969.
Education
Ph.D. in Molecular Biology and Biochemistry, University of California at Santa Barbara
M.A. in Molecular Biology and Biochemistry, University of California at Santa Barbara
B.A. in Biology, University of California at Santa Barbara
Awards
American Cancer Society Faculty Research Award,1977
